+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Therapeutic Hypothermia Systems Market by Product Type, Cooling Method, Application, End User, Temperature Control Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5967930
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Therapeutic Hypothermia Systems Market grew from USD 323.31 million in 2024 to USD 345.29 million in 2025. It is expected to continue growing at a CAGR of 6.74%, reaching USD 478.23 million by 2030.

Therapeutic Hypothermia’s Rising Role in Critical Care

The therapeutic hypothermia systems market has rapidly matured into a cornerstone of critical care interventions, driven by an ever-expanding body of clinical evidence supporting controlled cooling as a means to improve neurological and cardiac outcomes. Recent advances in device technology have broadened the spectrum of cooling modalities, enabling precision temperature management that was unattainable just a decade ago. As health systems worldwide strive to enhance post-incident recovery and long-term patient quality of life, the role of hypothermia protocols has taken on heightened significance.

This dynamic environment is shaped by converging factors: regulatory updates that promote standardized treatment guidelines, growing clinician familiarity with both intravascular and surface cooling methods, and an aging global population with rising comorbidities that benefit from neuroprotective strategies. Against this backdrop, stakeholders must navigate complex device portfolios, evolving reimbursement landscapes, and diverse clinical applications to seize emerging opportunities. This introduction sets the stage for a deeper exploration of transformative shifts, trade policy impacts, segmentation nuances, regional variances, competitive performance, and strategic imperatives needed to excel in this high-stakes domain.

Precision Cooling Recharts Treatment Pathways

The past few years have witnessed a seismic shift in the therapeutic hypothermia landscape as precision medicine principles converge with cutting-edge device innovation. Intravascular cooling technologies have gained traction alongside traditional surface methods, driven by enhanced temperature control algorithms, refined catheter designs, and integrated digital monitoring. These advancements have recalibrated clinician expectations for rapid induction of target temperatures while maintaining hemodynamic stability.

Simultaneously, the adoption curve for targeted normothermia has begun to accelerate, reframing the concept of controlled cooling as part of a broader temperature management continuum. This repositioning has unlocked new applications in post-surgical care, stroke management, and traumatic brain injury, moving beyond the historical focus on cardiac arrest and neonatal encephalopathy. As a result, investment in research and development has intensified, with alliances between device manufacturers and academic centers fostering real-world evidence generation. This transformative momentum underscores a broader trend toward personalization and outcome-driven care, promising to reshape clinical protocols and market dynamics in the coming years.

Navigating US Tariffs and Their Strategic Ripples

The imposition of new United States tariffs in 2025 has introduced a fresh layer of complexity for global suppliers and healthcare providers. Devices imported into the US market now face elevated duties, prompting manufacturers to reevaluate supply chain configurations and cost structures. For companies reliant on offshore production of catheters, gel packs, and water circulation systems, these tariffs have necessitated tougher negotiations with component suppliers and, in some cases, the relocation of final assembly operations to domestic facilities.

Healthcare providers have felt the ripple effects through increased list prices and extended procurement cycles. Some institutions have responded by consolidating vendor agreements or seeking long-term service contracts to hedge against further tariff adjustments. Meanwhile, certain market entrants have capitalized on the disruption by emphasizing domestically manufactured systems and accelerated service support. Although the tariffs ultimately aim to bolster local manufacturing, their short-term impact has been higher operating expenses and strategic reallocation of resources across the value chain.

Decoding Market Segments to Align Clinical Priorities

Disaggregating the market by product type reveals a clear dichotomy between surface and intravascular modalities. Blanket systems, ice packs, gel packs, pad systems, and water circulation units dominate the surface cooling segment, while catheter-based solutions bifurcate into balloon-based and fluid-based designs. This granularity allows providers to match device characteristics to specific patient profiles and treatment settings, optimizing efficacy and workflow integration.

When considering the underlying cooling method, intravascular approaches excel at rapid, uniform temperature reduction, offering unparalleled precision for critical scenarios. In contrast, surface cooling methods grant broader application versatility across emergency departments and homecare environments. Application-driven segmentation highlights cardiac arrest as the foundational use case, with neonatal encephalopathy, post-surgery temperature management, stroke care, and traumatic brain injury forming distinct clinical pathways that dictate protocol and device selection. End users range from ambulatory care centers and home settings to hospitals and specialized clinics, each with unique volume thresholds, staffing competencies, and capital expenditure constraints. Finally, temperature control differentiation between uncontrolled cooling and controlled temperature management-subdivided into targeted hypothermia and targeted normothermia-aligns product features with therapeutic objectives, ensuring that decision-makers can pinpoint the optimal device configuration for their clinical priorities.

Mapping Regional Dynamics for Strategic Expansion

Geographic dynamics further delineate the competitive terrain. Within the Americas, mature healthcare systems in North America drive early adoption of advanced hypothermia devices, while Latin American markets present cost-sensitivity and infrastructure challenges alongside pockets of high unmet need. Across Europe, the Middle East, and Africa, regional reimbursement policies, regulatory timelines, and the pace of guideline updates vary widely, requiring tailored market entry strategies and local partnerships to succeed. In Asia-Pacific, rapid urbanization and healthcare investment in key countries have set the stage for robust volume growth, although disparate regulatory frameworks and supply chain complexities demand flexible commercialization models.

Collectively, these regional nuances shape the allocation of R&D resources, post-market surveillance activities, and field service networks. They underscore the importance of aligning product portfolios with country-specific requirements and building agile distribution channels that can navigate reimbursement intricacies and local clinical education needs. Understanding these geographic contours is critical for companies aiming to capture both mature and emerging market opportunities.

Innovation Leaders and Collaborative Champions

Market leadership is defined by a combination of innovation, service excellence, and strategic alliances. Incumbent device manufacturers continue to fortify their positions through incremental product enhancements, embedding smarter temperature control algorithms and modular accessories to improve ease of use. Meanwhile, emerging challengers leverage nimble R&D cycles to introduce niche solutions tailored to specialty clinics and homecare scenarios, often securing early adopters through targeted clinical studies.

Cross-sector collaborations between medical device companies, pharmaceutical firms, and academic centers have also emerged as a hallmark of success. These partnerships facilitate the co-development of integrated care pathways that bundle cooling devices with neuroprotective agents or post-procedure monitoring platforms. Service differentiation in training, maintenance responsiveness, and remote monitoring capabilities further delineates the competitive hierarchy, influencing purchasing decisions among high-volume hospitals and expansive health networks. Companies that can harmonize these elements-technological prowess, clinical validation, and customer-centric services-are best positioned to maintain momentum in this rapidly evolving arena.

Strategic Imperatives to Drive Competitive Advantage

To seize advantage in this competitive landscape, industry participants must prioritize modular product development that accommodates both targeted hypothermia and normothermia protocols. Investing in scalable manufacturing footprints-whether through domestic assembly lines or localized partnerships-will mitigate the impact of trade policy fluctuations and compress lead times. Concurrently, forging clinical alliances with reference centers of excellence can accelerate adoption through peer-reviewed publications and inclusion in treatment guidelines.

Moreover, end-user education programs should be structured around experiential learning and real-world performance data, showcasing comparative outcomes between surface and intravascular techniques. Commercial teams should refine value propositions to emphasize total cost of ownership, ease of integration with existing patient monitoring ecosystems, and the potential for improved long-term recovery metrics. By blending technological differentiation, flexible supply chain strategies, and evidence-based sales enablement, market players can drive sustainable growth and fortify their positions against emerging entrants.

Methodological Rigor Underlying Our Insights

This analysis is founded on a rigorous, multi-stage research methodology that integrates comprehensive secondary research, expert interviews, and data triangulation. Publicly available literature, industry white papers, regulatory filings, and company disclosures were systematically reviewed to assemble a robust baseline of market intelligence. In parallel, in-depth interviews with clinicians, hospital procurement leaders, and device innovators provided qualitative insights into adoption barriers and clinical preferences.

Quantitative validation was achieved through cross-referencing proprietary shipment databases, capital expenditure reports, and regional sales figures. Advanced analytical frameworks-including SWOT and Porter’s Five Forces-were applied to distill competitive dynamics and identify growth enablers. Rigorous data verification protocols and peer review mechanisms ensured the accuracy and relevance of all findings. This methodological rigor underpins the strategic conclusions and recommendations presented throughout this executive summary.

Charting the Path Forward in Hypothermia Care

Ultimately, the therapeutic hypothermia systems market stands at an inflection point, with technological breakthroughs and evolving clinical paradigms converging to expand its therapeutic footprint. While tariff volatility and regional reimbursement complexities pose immediate challenges, these factors also catalyze supply chain innovation and local manufacturing initiatives. Segmentation analysis reveals clear growth corridors in neurology and post-surgical care, underscoring the need for tailored device portfolios and value-driven service models.

Competitive success will hinge on embracing modular design, fostering high-impact clinical partnerships, and deploying education platforms that translate performance data into actionable insights. Companies that adeptly navigate geopolitical shifts, decode end-user requirements, and articulate a compelling total cost of ownership narrative will emerge as market frontrunners. As the landscape continues to evolve, stakeholders who invest in precision, agility, and evidence-based differentiation will be well-positioned to lead the next wave of innovation in therapeutic hypothermia.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Blanket Systems
    • Catheter-Based Systems
      • Balloon-Based Catheters
      • Fluid-Based Catheters
    • Ice Packs & Gel Packs
    • Pad Systems
    • Water Circulation Systems
  • Cooling Method
    • Intravascular Cooling
    • Surface Cooling
      • Blanket Systems
      • Ice Packs & Gel Packs
      • Pad Systems
      • Water Circulation Systems
  • Application
    • Cardiac Arrest
    • Neonatal Encephalopathy
    • Post Surgery
    • Stroke
    • Traumatic Brain Injury
  • End User
    • Ambulatory Care Centers
    • Homecare Settings
    • Hospitals
    • Specialty Clinics
  • Temperature Control Type
    • Controlled Temperature Management
      • Targeted Hypothermia
      • Targeted Normothermia
    • Uncontrolled Cooling
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Stryker Corporation
  • C.R. Bard, Inc.
  • ZOLL Medical Corporation
  • B. Braun Melsungen AG
  • Drägerwerk AG & Co. KGaA
  • Koninklijke Philips N.V.
  • Fisher & Paykel Healthcare Corporation Limited
  • Haemonetics Corporation
  • Arizant Healthcare Inc.
  • Cincinnati Sub-Zero Products, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Therapeutic Hypothermia Systems Market, by Product Type
8.1. Introduction
8.2. Blanket Systems
8.3. Catheter-Based Systems
8.3.1. Balloon-Based Catheters
8.3.2. Fluid-Based Catheters
8.4. Ice Packs & Gel Packs
8.5. Pad Systems
8.6. Water Circulation Systems
9. Therapeutic Hypothermia Systems Market, by Cooling Method
9.1. Introduction
9.2. Intravascular Cooling
9.3. Surface Cooling
9.3.1. Blanket Systems
9.3.2. Ice Packs & Gel Packs
9.3.3. Pad Systems
9.3.4. Water Circulation Systems
10. Therapeutic Hypothermia Systems Market, by Application
10.1. Introduction
10.2. Cardiac Arrest
10.3. Neonatal Encephalopathy
10.4. Post Surgery
10.5. Stroke
10.6. Traumatic Brain Injury
11. Therapeutic Hypothermia Systems Market, by End User
11.1. Introduction
11.2. Ambulatory Care Centers
11.3. Homecare Settings
11.4. Hospitals
11.5. Specialty Clinics
12. Therapeutic Hypothermia Systems Market, by Temperature Control Type
12.1. Introduction
12.2. Controlled Temperature Management
12.2.1. Targeted Hypothermia
12.2.2. Targeted Normothermia
12.3. Uncontrolled Cooling
13. Americas Therapeutic Hypothermia Systems Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Therapeutic Hypothermia Systems Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Therapeutic Hypothermia Systems Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Stryker Corporation
16.3.2. C.R. Bard, Inc.
16.3.3. ZOLL Medical Corporation
16.3.4. B. Braun Melsungen AG
16.3.5. Drägerwerk AG & Co. KGaA
16.3.6. Koninklijke Philips N.V.
16.3.7. Fisher & Paykel Healthcare Corporation Limited
16.3.8. Haemonetics Corporation
16.3.9. Arizant Healthcare Inc.
16.3.10. Cincinnati Sub-Zero Products, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET MULTI-CURRENCY
FIGURE 2. THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET MULTI-LANGUAGE
FIGURE 3. THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2024 VS 2030 (%)
FIGURE 10. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BALLOON-BASED CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY FLUID-BASED CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY INTRAVASCULAR COOLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CARDIAC ARREST, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY NEONATAL ENCEPHALOPATHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY POST SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY STROKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED HYPOTHERMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED NORMOTHERMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY UNCONTROLLED COOLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. CANADA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 59. CANADA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 60. CANADA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 61. CANADA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 62. CANADA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. CANADA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. CANADA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 65. CANADA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 66. MEXICO THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. MEXICO THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 68. MEXICO THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 69. MEXICO THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 70. MEXICO THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. MEXICO THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. MEXICO THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 73. MEXICO THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 107. GERMANY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. GERMANY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 109. GERMANY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 110. GERMANY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 111. GERMANY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. GERMANY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. GERMANY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 114. GERMANY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 115. FRANCE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. FRANCE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 117. FRANCE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 118. FRANCE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 119. FRANCE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. FRANCE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. FRANCE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 122. FRANCE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. RUSSIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 130. RUSSIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 131. ITALY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. ITALY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 133. ITALY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 134. ITALY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 135. ITALY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. ITALY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. ITALY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 138. ITALY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 139. SPAIN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. SPAIN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 141. SPAIN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 142. SPAIN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 143. SPAIN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. SPAIN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. SPAIN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 146. SPAIN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 171. DENMARK THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 172. DENMARK THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 173. DENMARK THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 174. DENMARK THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 175. DENMARK THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. DENMARK THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. DENMARK THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 178. DENMARK THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. NETHERLANDS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 186. NETHERLANDS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 187. QATAR THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. QATAR THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 189. QATAR THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 190. QATAR THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 191. QATAR THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. QATAR THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. QATAR THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 194. QATAR THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 195. FINLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 196. FINLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 197. FINLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 198. FINLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 199. FINLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. FINLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. FINLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 202. FINLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 218. NIGERIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 219. EGYPT THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. EGYPT THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 221. EGYPT THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 222. EGYPT THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 223. EGYPT THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. EGYPT THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. EGYPT THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 226. EGYPT THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 227. TURKEY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 228. TURKEY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 229. TURKEY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 230. TURKEY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 231. TURKEY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. TURKEY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. TURKEY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 234. TURKEY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 243. NORWAY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 244. NORWAY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 245. NORWAY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 246. NORWAY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 247. NORWAY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. NORWAY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. NORWAY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 250. NORWAY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 251. POLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 252. POLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 253. POLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 254. POLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 255. POLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. POLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. POLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 258. POLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 276. CHINA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. CHINA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 278. CHINA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 279. CHINA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 280. CHINA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. CHINA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. CHINA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 283. CHINA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 284. INDIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 285. INDIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 286. INDIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2030 (USD MILLION)
TABLE 287. INDIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2030 (USD MILLION)
TABLE 288. INDIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. INDIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. INDIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2030 (USD MILLION)
TABLE 291. INDIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 292. JAPAN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 293. JAPAN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2030 (USD MIL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Therapeutic Hypothermia Systems market report include:
  • Stryker Corporation
  • C.R. Bard, Inc.
  • ZOLL Medical Corporation
  • B. Braun Melsungen AG
  • Drägerwerk AG & Co. KGaA
  • Koninklijke Philips N.V.
  • Fisher & Paykel Healthcare Corporation Limited
  • Haemonetics Corporation
  • Arizant Healthcare Inc.
  • Cincinnati Sub-Zero Products, Inc.

Table Information